GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CODX · Dec 31, 2024

Co-Diagnostics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001641172-25-000932General Corporate
Capex intensity38thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

19.11% · OPTIONAL · VALID

Operating cash generation50thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-744.67% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-42.53% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure25thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

27.40% · OPTIONAL · VALID

Gross margin63thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.gross_margin

74.48% · CORE · VALID

Operating margin50thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

-1023.75% · CORE · VALID

R&D intensity50thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

535.86% · OPTIONAL · VALID

SBC intensity50thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

138.82% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20257/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
27.21%
Current
19.11%
Delta
-8.09%
Cash Generation Increased
Previous
-1127.60%
Current
-744.67%
Delta
382.93%
Growth Increased
Previous
-73.91%
Current
-42.53%
Delta
31.38%
Inventory Pressure Decreased
Previous
197.46%
Current
27.40%
Delta
-170.06%
Margin Increased
Previous
53.61%
Current
74.48%
Delta
20.87%
Profitability Increased
Previous
-1596.36%
Current
-1023.75%
Delta
572.62%
R And D Intensity Decreased
Previous
761.19%
Current
535.86%
Delta
-225.34%
Sbc Intensity Decreased
Previous
163.08%
Current
138.82%
Delta
-24.26%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · CODX Fundamental State →Has State · Co-Diagnostics, Inc. →Transitioned To · CODX Fundamental State →Transitioned To · CODX CAPEX_INTENSITY_DECREASED →Transitioned To · CODX CASH_GENERATION_INCREASED →Transitioned To · CODX GROWTH_INCREASED →Transitioned To · CODX INVENTORY_PRESSURE_DECREASED →Transitioned To · CODX MARGIN_INCREASED →Transitioned To · CODX PROFITABILITY_INCREASED →Transitioned To · CODX R_AND_D_INTENSITY_DECREASED →Transitioned To · CODX SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.